19 terminated. 19 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 19 | Terminated 19 |
Follow Prostatic Diseases: new trials by email Literature Review of Prostatic Diseases trials Research Report on Prostatic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Contributions to Hypertension With Androgen Deprivation Therapy Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor, Placebo - Androgen Deprivation Therapy, Prostate Cancer | Phase 4 | Terminated | University of Colorado, Denver | 10 | 2023-09-20 | 2026-09-02 |
| (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes .5% Bupivacaine - Prostate Cancer, Hot Flashes | Phase 4 | Terminated | Northwestern University | 1 | 2019-11-13 | 2023-01-25 |
| An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer Computed Tomography, Fluciclovine F18, Positron Emission Tomography - Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 4 | Terminated | M.D. Anderson Cancer Center | 2 | 2019-09-19 | 2025-01-16 |
| Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution, 0.9% Sodium Chloride Injection - Kidney Cancer, Prostate Cancer | Phase 4 | Terminated | University of Missouri-Columbia | 21 | 2019-02-26 | 2023-10-25 |
| PREvention of VENous ThromboEmbolism Following Radical Prostatectomy Subcutaneous Heparin - Prostate Cancer, Venous Thromboembolism | Phase 4 | Terminated | Johns Hopkins University | 501 | 2017-07-01 | 2020-08-05 |
| A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment Enzalutamide - Metastatic Castration Resistant Prostate Cancer | Phase 4 | Terminated | Astellas Pharma Global Development, Inc. | 4 | 2015-10-28 | 2018-04-19 |
| A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease Eligard - Metastatic Prostate Cancer | Phase 4 | Terminated | Astellas Pharma Europe Ltd. | 1 | 2014-08-01 | 2017-03-09 |
| Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning Prostate HistoScanning - Prostate Cancer | Phase 4 | Terminated | Advanced Medical Diagnostics s.a. | 80 | 2013-10-01 | 2015-01-05 |
| Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain D-Cycloserine, Placebo (for D-cycloserine) - Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Phase 4 | Terminated | Northwestern University | 24 | 2013-09-01 | 2023-05-17 |
| Efficacy of Gralise® for Chronic Pelvic Pain Gralise - Irritable Bowel Syndrome, Ulcerative Colitis | Phase 4 | Terminated | Shirley Ryan AbilityLab | 11 | 2012-08-01 | 2015-06-29 |
| GP Extended Action Triptorelin Decapeptyl® SR 22.5mg, Decapeptyl® SR 11.25mg; Prostap® 3 DCS 11.25mg; Zoladex® LA 10.8mg - Prostate Cancer | Phase 4 | Terminated | Ipsen | 27 | 2012-08-01 | 2025-05-23 |
| Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia Dutasteride/Tamsulosin - Prostatic Hyperplasia | Phase 4 | Terminated | GlaxoSmithKline | 59 | 2012-06-29 | 2018-08-20 |
| Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy Robotic Radical Prostatectomy, Open Radical Prostatectomy - Prostatic Neoplasms, Adenocarcinoma | Phase 4 | Terminated | Mayo Clinic | 10 | 2011-05-01 | 2014-06-02 |
| Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial Radical prostatectomy with implantation of allograft, Radical prostatectomy without implantation of allograft - Erectile Dysfunction Following Radical Prostatectomy | Phase 4 | Terminated | Kantonsspital Winterthur KSW | 30 | 2011-01-01 | 2021-02-21 |
| Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter Dutasteride - Benign Prostatic Hyperplasia | Phase 4 | Terminated | GlaxoSmithKline | 276 | 2007-03-01 | 2007-11-27 |
| Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III Viagra (sildenafil citrate) - Prostatitis | Phase 4 | Terminated | University of Washington | 30 | 2004-07-01 | 2008-10-22 |
| Dissemination of Prostate Cancer Screening to PCP's in African American Communities Academic Detailing - Prostate Cancer | Phase 4 | Terminated | Columbia University | 86 | 2004-01-01 | 2015-10-14 |
| Botox as a Treatment for Chronic Male Pelvic Pain Syndrome Botulinum Toxin A (Botox) - Chronic Male Pelvic Pain Syndrome | Phase 4 | Terminated | University of Washington | 30 | 2003-08-01 | 2007-10-19 |
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer Trelstar, Lupron, Zoladex - Prostate Cancer | Phase 4 | Terminated | Pharmatech | 41 | 2002-09-01 | 2016-04-25 |
Prostatic Neoplasms (13) · Prostatitis (4) · Prostatic Hyperplasia (2) · Adenocarcinoma (1) · Colitis, Ulcerative (1) · Cystitis, Interstitial (1) · Hot Flashes (1) · Hypertension (1) · Irritable Bowel Syndrome (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Pain (1) · Pelvic Pain (1)
Genital Diseases (19) · Genital Diseases, Male (19) · Male Urogenital Diseases (19) · Urogenital Diseases (19) · Genital Neoplasms, Male (13) · Neoplasms by Site (13) · Urogenital Neoplasms (13) · Neoplasms (12) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Pathological Conditions, Signs and Symptoms (3) · Urologic Diseases (3) · Cardiovascular Diseases (2) · Signs and Symptoms (2)
Goserelin (3) · Leuprolide (3) · Dutasteride (2) · Triptorelin Pamoate (2) · enzalutamide (2) · Acetaminophen (1) · Botulinum Toxins, Type A (1) · Bupivacaine (1) · Cycloserine (1) · Flutamide (1) · Gabapentin (1) · Glucose (1) · Lidocaine (1) · Magnetic Resonance Spectroscopy (1) · Receptors, Androgen (1)
GlaxoSmithKline (2) · Northwestern University (2) · University of Washington (2) · Advanced Medical Diagnostics s.a. (1) · Astellas Pharma Europe Ltd. (1) · Astellas Pharma Global Development, Inc. (1) · Columbia University (1) · Ipsen (1) · Johns Hopkins University (1) · Kantonsspital Winterthur KSW (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Pharmatech (1) · Shirley Ryan AbilityLab (1) · University of Colorado, Denver (1)
United States (11) · United Kingdom (3) · Netherlands (2) · Switzerland (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Czechia (1) · Denmark (1) · Estonia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Latvia (1)
Richard E Berger, MD (2) · Bertrand Tombal, Prof (1) · Boris Mraovic, MD (1) · David Walega, MD, MS (1) · Gregory C Ravizzini (1) · Hubert John, Chefarzt (1) · Matthew Babcock, PhD (1) · Michael Michael Manyak, MD (1) · Mohamad E Allaf, MD (1) · Norman Harden, MD (1)
PMID 30352714, PMID 31643128, PMID 32444264
R01DK100924 (1)